La Roche-Posay Effaclar Salicylic Acid Acne Treatment Serum
This lightweight salicylic acid acne treatment serum clears acne blemishes and helps prevent new breakouts, while also visibly reducing pores, fine lines, and post-acne marks.
This serum includes Triple Acid Complex, a blend of 1.5% salicylic acid, glycolic acid, and micro-exfoliating lipo-hydroxy acid for optimal efficacy.
This formula also includes Niacinamide and La Roche-Posay Thermal Water to help soothe skin and minimize skin irritation.
Take your health to the next level with FSA eligible Skin & Personal Care products.
- Clears acne blemishes and helps prevent new breakouts
- Visibly reduces pores, fine lines, and post-acne marks
- 21% reduction of whiteheads and blackheads in 4 weeks
- 77% agree pores appear less visible in 2 weeks
- 45% reduction of pimples in 4 weeks
- 49% improvement of post-acne marks in 4 weeks
SALICYLIC ACID 1.5%
WATER • ALCOHOL DENAT. • PROPANEDIOL • GLYCOLIC ACID • NIACINAMIDE • DIMETHYL ISOSORBIDE • PENTYLENE GLYCOL • SODIUM HYDROXIDE • PPG-26-BUTETH-26 • HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID • CITRIC ACID • PEG-30 GLYCERYL COCOATE • PEG-40 HYDROGENATED CASTOR OIL • PEG-60 HYDROGENATED CASTOR OIL • CAPRYLOYL SALICYLIC ACID • BIOSACCHARIDE GUM-1 • MALTODEXTRIN • PHYTIC ACID • POLYQUATERNIUM-10 • FRAGRANCE
Step 1: Shake well for even application.
Step 2: Apply the entire affected area with a thin layer after cleansing face. Do not rinse off. Start with one application daily, then gradually increase to two or three times daily if needed.
Step 3: In the daytime, apply daily sun protection. Avoid eye area.
*Do not use on peeling or compromised skin. Avoid the eye contour and contact with eyes.
*This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.
Please note that we are unable to ship this product outside the contiguous United States. We apologize for the inconvenience.